Cite

HARVARD Citation

    Lansky, A. et al. (2021). A randomized evaluation of the TriGuard™ HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial. European heart journal. pp. 2670-2679. [Online].

Back to record